BRIEF—Sobi's Tony Hoos lasts less than a quarter in top research role

Tony Hoos, who only took over as head of R&D and medical affairs (RDMA) and chief medical officer (CMO) at Swedish Orphan Biovitrum in April, is to leave the Stockholm-based biotech firm, it has been announced.

Lydia Abad-Franch, currently head of medical affairs and clinical science, has been appointed acting CMO.

She will lead the RDMA function in close collaboration with the RDMA leadership team, supported by board member and former head of RDMA and CMO Anders Ullman, until a permanent appointment is made.